Select Medical Holdings Corporation (NYSE: SEM) Stock Competitors & Peer Comparison

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, HCA has a market cap of 90.6B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while HCA trades at $408.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas HCA's P/E ratio is 14.10. In terms of profitability, SEM's ROE is +0.08%, compared to HCA's ROE of -1.13%. Regarding short-term risk, SEM is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for SEM.Check HCA's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, THC has a market cap of 22.2B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while THC trades at $257.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas THC's P/E ratio is 14.95. In terms of profitability, SEM's ROE is +0.08%, compared to THC's ROE of +0.51%. Regarding short-term risk, SEM is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for SEM.Check THC's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, DVA has a market cap of 15.5B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while DVA trades at $240.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas DVA's P/E ratio is 20.54. In terms of profitability, SEM's ROE is +0.08%, compared to DVA's ROE of -1.33%. Regarding short-term risk, SEM is less volatile compared to DVA. This indicates lower risk in terms of short-term price fluctuations for SEM.Check DVA's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, SOLV has a market cap of 15.3B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while SOLV trades at $88.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas SOLV's P/E ratio is 14.19. In terms of profitability, SEM's ROE is +0.08%, compared to SOLV's ROE of +0.31%. Regarding short-term risk, SEM is less volatile compared to SOLV. This indicates lower risk in terms of short-term price fluctuations for SEM.Check SOLV's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, FMS has a market cap of 13.4B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while FMS trades at $24.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas FMS's P/E ratio is 9.87. In terms of profitability, SEM's ROE is +0.08%, compared to FMS's ROE of +0.07%. Regarding short-term risk, SEM is less volatile compared to FMS. This indicates lower risk in terms of short-term price fluctuations for SEM.Check FMS's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, EHC has a market cap of 11.3B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while EHC trades at $113.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas EHC's P/E ratio is 20.00. In terms of profitability, SEM's ROE is +0.08%, compared to EHC's ROE of +0.25%. Regarding short-term risk, SEM is less volatile compared to EHC. This indicates lower risk in terms of short-term price fluctuations for SEM.Check EHC's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, ENSG has a market cap of 10.6B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while ENSG trades at $181.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas ENSG's P/E ratio is 26.36. In terms of profitability, SEM's ROE is +0.08%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, SEM is less volatile compared to ENSG. This indicates lower risk in terms of short-term price fluctuations for SEM.Check ENSG's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, UHS has a market cap of 10.2B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while UHS trades at $168.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas UHS's P/E ratio is 7.45. In terms of profitability, SEM's ROE is +0.08%, compared to UHS's ROE of +0.21%. Regarding short-term risk, SEM is less volatile compared to UHS. This indicates lower risk in terms of short-term price fluctuations for SEM.Check UHS's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while OSH trades at $39.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas OSH's P/E ratio is -17.65. In terms of profitability, SEM's ROE is +0.08%, compared to OSH's ROE of +4.64%. Regarding short-term risk, SEM is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for SEM.Check OSH's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, PACS has a market cap of 7.4B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while PACS trades at $46.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas PACS's P/E ratio is 39.49. In terms of profitability, SEM's ROE is +0.08%, compared to PACS's ROE of +0.27%. Regarding short-term risk, SEM is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for SEM.Check PACS's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, CHE has a market cap of 7.2B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while CHE trades at $539.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas CHE's P/E ratio is 24.99. In terms of profitability, SEM's ROE is +0.08%, compared to CHE's ROE of +0.29%. Regarding short-term risk, SEM is less volatile compared to CHE. This indicates lower risk in terms of short-term price fluctuations for SEM.Check CHE's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while LHCG trades at $169.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas LHCG's P/E ratio is 82.83. In terms of profitability, SEM's ROE is +0.08%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, SEM is less volatile compared to LHCG. This indicates lower risk in terms of short-term price fluctuations for SEM.Check LHCG's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, LFST has a market cap of 4.2B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while LFST trades at $10.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas LFST's P/E ratio is 173.01. In terms of profitability, SEM's ROE is +0.08%, compared to LFST's ROE of +0.02%. Regarding short-term risk, SEM is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for SEM.Check LFST's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, CON has a market cap of 4B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while CON trades at $31.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas CON's P/E ratio is 21.94. In terms of profitability, SEM's ROE is +0.08%, compared to CON's ROE of +0.46%. Regarding short-term risk, SEM is less volatile compared to CON. This indicates lower risk in terms of short-term price fluctuations for SEM.Check CON's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, OPCH has a market cap of 3.8B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while OPCH trades at $23.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas OPCH's P/E ratio is 13.91. In terms of profitability, SEM's ROE is +0.08%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, SEM is less volatile compared to OPCH. This indicates lower risk in terms of short-term price fluctuations for SEM.Check OPCH's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, NHC has a market cap of 3.6B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while NHC trades at $228.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas NHC's P/E ratio is 32.86. In terms of profitability, SEM's ROE is +0.08%, compared to NHC's ROE of +0.12%. Regarding short-term risk, SEM is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for SEM.Check NHC's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, BKD has a market cap of 3.5B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while BKD trades at $14.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas BKD's P/E ratio is -25.63. In terms of profitability, SEM's ROE is +0.08%, compared to BKD's ROE of +401.19%. Regarding short-term risk, SEM is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for SEM.Check BKD's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while AMED trades at $100.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas AMED's P/E ratio is 39.30. In terms of profitability, SEM's ROE is +0.08%, compared to AMED's ROE of +0.11%. Regarding short-term risk, SEM is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for SEM.Check AMED's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, ACHC has a market cap of 2.5B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while ACHC trades at $27.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas ACHC's P/E ratio is 13.74. In terms of profitability, SEM's ROE is +0.08%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, SEM is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for SEM.Check ACHC's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while ADUS trades at $119.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas ADUS's P/E ratio is 18.50. In terms of profitability, SEM's ROE is +0.08%, compared to ADUS's ROE of +0.09%. Regarding short-term risk, SEM is less volatile compared to ADUS. This indicates lower risk in terms of short-term price fluctuations for SEM.Check ADUS's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while MD trades at $26.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas MD's P/E ratio is 12.49. In terms of profitability, SEM's ROE is +0.08%, compared to MD's ROE of +0.20%. Regarding short-term risk, SEM is less volatile compared to MD. This indicates lower risk in terms of short-term price fluctuations for SEM.Check MD's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, SGRY has a market cap of 2.1B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while SGRY trades at $16.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas SGRY's P/E ratio is 42.08. In terms of profitability, SEM's ROE is +0.08%, compared to SGRY's ROE of -0.04%. Regarding short-term risk, SEM is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for SEM.Check SGRY's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, AVAH has a market cap of 2.1B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while AVAH trades at $9.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas AVAH's P/E ratio is 14.34. In terms of profitability, SEM's ROE is +0.08%, compared to AVAH's ROE of +2.41%. Regarding short-term risk, SEM is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for SEM.Check AVAH's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while AMEH trades at $40.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas AMEH's P/E ratio is 39.25. In terms of profitability, SEM's ROE is +0.08%, compared to AMEH's ROE of +0.04%. Regarding short-term risk, SEM is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for SEM.Check AMEH's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, ASTH has a market cap of 1.8B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while ASTH trades at $36.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas ASTH's P/E ratio is 24.67. In terms of profitability, SEM's ROE is +0.08%, compared to ASTH's ROE of +0.04%. Regarding short-term risk, SEM is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for SEM.Check ASTH's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, HCSG has a market cap of 1.6B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while HCSG trades at $23.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas HCSG's P/E ratio is 18.74. In terms of profitability, SEM's ROE is +0.08%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, SEM is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for SEM.Check HCSG's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while ARDT trades at $10.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas ARDT's P/E ratio is 6.66. In terms of profitability, SEM's ROE is +0.08%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, SEM is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for SEM.Check ARDT's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, INNV has a market cap of 1.6B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while INNV trades at $11.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas INNV's P/E ratio is -127.44. In terms of profitability, SEM's ROE is +0.08%, compared to INNV's ROE of -0.09%. Regarding short-term risk, SEM is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for SEM.Check INNV's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while AGL trades at $92.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas AGL's P/E ratio is -9.13. In terms of profitability, SEM's ROE is +0.08%, compared to AGL's ROE of -1.46%. Regarding short-term risk, SEM is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for SEM.Check AGL's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, CMPS has a market cap of 1.5B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while CMPS trades at $10.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas CMPS's P/E ratio is -5.32. In terms of profitability, SEM's ROE is +0.08%, compared to CMPS's ROE of -1.51%. Regarding short-term risk, SEM is less volatile compared to CMPS. This indicates lower risk in terms of short-term price fluctuations for SEM.Check CMPS's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while PNTG trades at $41.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas PNTG's P/E ratio is 33.40. In terms of profitability, SEM's ROE is +0.08%, compared to PNTG's ROE of +0.09%. Regarding short-term risk, SEM is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for SEM.Check PNTG's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while AMN trades at $34.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas AMN's P/E ratio is 11.51. In terms of profitability, SEM's ROE is +0.08%, compared to AMN's ROE of -0.05%. Regarding short-term risk, SEM is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for SEM.Check AMN's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while BKDT trades at $77.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas BKDT's P/E ratio is N/A. In terms of profitability, SEM's ROE is +0.08%, compared to BKDT's ROE of +401.19%. Regarding short-term risk, SEM is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for SEM.Check BKDT's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while USPH trades at $79.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas USPH's P/E ratio is 30.75. In terms of profitability, SEM's ROE is +0.08%, compared to USPH's ROE of +0.00%. Regarding short-term risk, SEM is less volatile compared to USPH. This indicates lower risk in terms of short-term price fluctuations for SEM.Check USPH's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, NUTX has a market cap of 966.8M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while NUTX trades at $140.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas NUTX's P/E ratio is 10.86. In terms of profitability, SEM's ROE is +0.08%, compared to NUTX's ROE of +0.31%. Regarding short-term risk, SEM is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for SEM.Check NUTX's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, FSHCX has a market cap of 906.7M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while FSHCX trades at $119.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas FSHCX's P/E ratio is N/A. In terms of profitability, SEM's ROE is +0.08%, compared to FSHCX's ROE of N/A. Regarding short-term risk, SEM is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for SEM.Check FSHCX's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, TALK has a market cap of 874.4M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while TALK trades at $5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas TALK's P/E ratio is 769.91. In terms of profitability, SEM's ROE is +0.08%, compared to TALK's ROE of +0.01%. Regarding short-term risk, SEM is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for SEM.Check TALK's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, SNDA has a market cap of 815.1M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while SNDA trades at $40.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas SNDA's P/E ratio is -7.55. In terms of profitability, SEM's ROE is +0.08%, compared to SNDA's ROE of -0.35%. Regarding short-term risk, SEM is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for SEM.Check SNDA's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while EHAB trades at $13.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas EHAB's P/E ratio is -197.14. In terms of profitability, SEM's ROE is +0.08%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, SEM is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for SEM.Check EHAB's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, GMRS has a market cap of 593.1M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while GMRS trades at $12.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas GMRS's P/E ratio is 5.76. In terms of profitability, SEM's ROE is +0.08%, compared to GMRS's ROE of +1.01%. Regarding short-term risk, SEM is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for SEM.Check GMRS's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, TOIIW has a market cap of 490.9M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while TOIIW trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas TOIIW's P/E ratio is -0.18. In terms of profitability, SEM's ROE is +0.08%, compared to TOIIW's ROE of +3.27%. Regarding short-term risk, SEM is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for SEM.Check TOIIW's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, TOI has a market cap of 476.9M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while TOI trades at $4.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas TOI's P/E ratio is -13.25. In terms of profitability, SEM's ROE is +0.08%, compared to TOI's ROE of +3.27%. Regarding short-term risk, SEM is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for SEM.Check TOI's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, VMD has a market cap of 446.6M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while VMD trades at $11.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas VMD's P/E ratio is 31.49. In terms of profitability, SEM's ROE is +0.08%, compared to VMD's ROE of +0.11%. Regarding short-term risk, SEM is less volatile compared to VMD. This indicates lower risk in terms of short-term price fluctuations for SEM.Check VMD's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while MCTA trades at $29.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas MCTA's P/E ratio is 419.36. In terms of profitability, SEM's ROE is +0.08%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, SEM is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for SEM.Check MCTA's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, SRTA has a market cap of 421.4M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while SRTA trades at $4.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas SRTA's P/E ratio is -34.26. In terms of profitability, SEM's ROE is +0.08%, compared to SRTA's ROE of +0.18%. Regarding short-term risk, SEM is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for SEM.Check SRTA's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, AUNA has a market cap of 384.9M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while AUNA trades at $5.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas AUNA's P/E ratio is 4.68. In terms of profitability, SEM's ROE is +0.08%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, SEM is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for SEM.Check AUNA's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, CYH has a market cap of 382.1M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while CYH trades at $2.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas CYH's P/E ratio is 3.71. In terms of profitability, SEM's ROE is +0.08%, compared to CYH's ROE of +0.21%. Regarding short-term risk, SEM is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for SEM.Check CYH's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, AIRS has a market cap of 307.2M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while AIRS trades at $4.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas AIRS's P/E ratio is -145.17. In terms of profitability, SEM's ROE is +0.08%, compared to AIRS's ROE of -0.12%. Regarding short-term risk, SEM is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for SEM.Check AIRS's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while CSU trades at $33.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas CSU's P/E ratio is 0.67. In terms of profitability, SEM's ROE is +0.08%, compared to CSU's ROE of -0.51%. Regarding short-term risk, SEM is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for SEM.Check CSU's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, JYNT has a market cap of 118.9M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while JYNT trades at $8.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas JYNT's P/E ratio is 83.40. In terms of profitability, SEM's ROE is +0.08%, compared to JYNT's ROE of +0.17%. Regarding short-term risk, SEM is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for SEM.Check JYNT's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while FVE trades at $2.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas FVE's P/E ratio is -5.64. In terms of profitability, SEM's ROE is +0.08%, compared to FVE's ROE of -0.15%. Regarding short-term risk, SEM is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for SEM.Check FVE's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while KDLYW trades at $18.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas KDLYW's P/E ratio is N/A. In terms of profitability, SEM's ROE is +0.08%, compared to KDLYW's ROE of -0.85%. Regarding short-term risk, SEM is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for SEM.Check KDLYW's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, BTMD has a market cap of 90M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while BTMD trades at $2.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas BTMD's P/E ratio is 4.64. In terms of profitability, SEM's ROE is +0.08%, compared to BTMD's ROE of -0.23%. Regarding short-term risk, SEM is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for SEM.Check BTMD's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, DCGO has a market cap of 64.2M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while DCGO trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas DCGO's P/E ratio is -0.75. In terms of profitability, SEM's ROE is +0.08%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, SEM is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for SEM.Check DCGO's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while ALR trades at $1.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas ALR's P/E ratio is -1.11. In terms of profitability, SEM's ROE is +0.08%, compared to ALR's ROE of -0.15%. Regarding short-term risk, SEM is less volatile compared to ALR. This indicates lower risk in terms of short-term price fluctuations for SEM.Check ALR's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, PARK has a market cap of 35M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while PARK trades at $17.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas PARK's P/E ratio is 24.30. In terms of profitability, SEM's ROE is +0.08%, compared to PARK's ROE of -0.24%. Regarding short-term risk, SEM is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for SEM.Check PARK's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, PIII has a market cap of 34.8M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while PIII trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas PIII's P/E ratio is -0.27. In terms of profitability, SEM's ROE is +0.08%, compared to PIII's ROE of +1.85%. Regarding short-term risk, SEM is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for SEM.Check PIII's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while IMAC trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas IMAC's P/E ratio is -2.27. In terms of profitability, SEM's ROE is +0.08%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, SEM is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for SEM.Check IMAC's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, CCEL has a market cap of 28.2M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while CCEL trades at $3.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas CCEL's P/E ratio is -10.61. In terms of profitability, SEM's ROE is +0.08%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, SEM is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for SEM.Check CCEL's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while CANO-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, SEM's ROE is +0.08%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, SEM is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for SEM.Check CANO-WT's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while AIH trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas AIH's P/E ratio is -2.78. In terms of profitability, SEM's ROE is +0.08%, compared to AIH's ROE of +1.16%. Regarding short-term risk, SEM is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for SEM.Check AIH's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while CANO trades at $2.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas CANO's P/E ratio is -0.01. In terms of profitability, SEM's ROE is +0.08%, compared to CANO's ROE of -1.49%. Regarding short-term risk, SEM is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for SEM.Check CANO's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, AMS has a market cap of 10.5M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while AMS trades at $1.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas AMS's P/E ratio is -7.10. In terms of profitability, SEM's ROE is +0.08%, compared to AMS's ROE of -0.06%. Regarding short-term risk, SEM is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for SEM.Check AMS's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while FPCG trades at $1,025.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas FPCG's P/E ratio is 0.09. In terms of profitability, SEM's ROE is +0.08%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, SEM is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for SEM.Check FPCG's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while FTRP trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas FTRP's P/E ratio is -1.22. In terms of profitability, SEM's ROE is +0.08%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, SEM is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for SEM.Check FTRP's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, BMGL has a market cap of 8.9M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while BMGL trades at $5.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas BMGL's P/E ratio is -1.08. In terms of profitability, SEM's ROE is +0.08%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, SEM is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for SEM.Check BMGL's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, XWEL has a market cap of 6.5M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while XWEL trades at $1.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas XWEL's P/E ratio is -0.32. In terms of profitability, SEM's ROE is +0.08%, compared to XWEL's ROE of +2.89%. Regarding short-term risk, SEM is less volatile compared to XWEL. This indicates lower risk in terms of short-term price fluctuations for SEM.Check XWEL's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while MODV trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas MODV's P/E ratio is -0.06. In terms of profitability, SEM's ROE is +0.08%, compared to MODV's ROE of +1.36%. Regarding short-term risk, SEM is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for SEM.Check MODV's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while GBNH trades at $0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas GBNH's P/E ratio is -0.06. In terms of profitability, SEM's ROE is +0.08%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, SEM is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for SEM.Check GBNH's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while RHE trades at $2.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas RHE's P/E ratio is -1.79. In terms of profitability, SEM's ROE is +0.08%, compared to RHE's ROE of -0.36%. Regarding short-term risk, SEM is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for SEM.Check RHE's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while RHE-PA trades at $0.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, SEM's ROE is +0.08%, compared to RHE-PA's ROE of +2.11%. Regarding short-term risk, SEM is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for SEM.Check RHE-PA's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, AIDX has a market cap of 2.5M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while AIDX trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas AIDX's P/E ratio is -0.83. In terms of profitability, SEM's ROE is +0.08%, compared to AIDX's ROE of +0.79%. Regarding short-term risk, SEM is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for SEM.Check AIDX's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while IMACW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas IMACW's P/E ratio is N/A. In terms of profitability, SEM's ROE is +0.08%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, SEM is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for SEM.Check IMACW's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while NAKAW trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, SEM's ROE is +0.08%, compared to NAKAW's ROE of -0.85%. Regarding short-term risk, SEM is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for SEM.Check NAKAW's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, CCM has a market cap of 642.2K. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while CCM trades at $4.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas CCM's P/E ratio is -0.30. In terms of profitability, SEM's ROE is +0.08%, compared to CCM's ROE of +0.06%. Regarding short-term risk, SEM is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for SEM.Check CCM's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, NIVF has a market cap of 159.8K. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while NIVF trades at $0.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas NIVF's P/E ratio is 0.42. In terms of profitability, SEM's ROE is +0.08%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, SEM is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for SEM.Check NIVF's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, MNDR has a market cap of 41.1K. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while MNDR trades at $1.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas MNDR's P/E ratio is -0.04. In terms of profitability, SEM's ROE is +0.08%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, SEM is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for SEM.Check MNDR's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, NIVFW has a market cap of 39.1K. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while NIVFW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, SEM's ROE is +0.08%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, SEM is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for SEM.Check NIVFW's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while TALKW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas TALKW's P/E ratio is 0.00. In terms of profitability, SEM's ROE is +0.08%, compared to TALKW's ROE of +0.01%. Regarding short-term risk, SEM is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for SEM.Check TALKW's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while TLMDW trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas TLMDW's P/E ratio is N/A. In terms of profitability, SEM's ROE is +0.08%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, SEM is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for SEM.Check TLMDW's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while ATIP-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, SEM's ROE is +0.08%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, SEM is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for SEM.Check ATIP-WT's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while SLHGP trades at $12.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, SEM's ROE is +0.08%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, SEM is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for SEM.Check SLHGP's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while SLHG trades at $0.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas SLHG's P/E ratio is -1.48. In terms of profitability, SEM's ROE is +0.08%, compared to SLHG's ROE of N/A. Regarding short-term risk, SEM is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for SEM.Check SLHG's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while AFAM trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas AFAM's P/E ratio is N/A. In terms of profitability, SEM's ROE is +0.08%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, SEM is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for SEM.Check AFAM's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while TLMD trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas TLMD's P/E ratio is -1.60. In terms of profitability, SEM's ROE is +0.08%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, SEM is less volatile compared to TLMD. This indicates lower risk in terms of short-term price fluctuations for SEM.Check TLMD's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, KND has a market cap of 0. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while KND trades at $9.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas KND's P/E ratio is -1.14. In terms of profitability, SEM's ROE is +0.08%, compared to KND's ROE of -0.53%. Regarding short-term risk, SEM is less volatile compared to KND. This indicates lower risk in terms of short-term price fluctuations for SEM.Check KND's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while DVCR trades at $10.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas DVCR's P/E ratio is 28.34. In terms of profitability, SEM's ROE is +0.08%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, SEM is less volatile compared to DVCR. This indicates lower risk in terms of short-term price fluctuations for SEM.Check DVCR's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while HNGR trades at $18.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas HNGR's P/E ratio is 19.71. In terms of profitability, SEM's ROE is +0.08%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, SEM is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for SEM.Check HNGR's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, NFH has a market cap of 0. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while NFH trades at $11.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas NFH's P/E ratio is -19.75. In terms of profitability, SEM's ROE is +0.08%, compared to NFH's ROE of -0.06%. Regarding short-term risk, SEM is less volatile compared to NFH. This indicates lower risk in terms of short-term price fluctuations for SEM.Check NFH's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while TVTY trades at $32.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas TVTY's P/E ratio is 19.06. In terms of profitability, SEM's ROE is +0.08%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, SEM is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for SEM.Check TVTY's competition here

Select Medical Holdings Corporation (NYSE: SEM) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SEM stands at 2B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, SEM is priced at $16.51 on the NYSE, while DCGOW trades at $1.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SEM currently has a P/E ratio of 15.43, whereas DCGOW's P/E ratio is N/A. In terms of profitability, SEM's ROE is +0.08%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, SEM is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for SEM.Check DCGOW's competition here